Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Sep 08 2021

Sep 8, 2021 at 3:56 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated September 08, 2021, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR LABETALOL HYDROCHLORIDE INJECTION USP".

View Attachment